On May 16, 2023, the US Court of Appeals for the Second Circuit affirmed the Southern District of New York’s order dismissing an action brought by investors of AstraZeneca PLC (AstraZeneca) attempting to hold the company...more
6/19/2023
/ AstraZeneca ,
Class Action ,
Clinical Trials ,
Dismissals ,
Material Misstatements ,
Pharmaceutical Industry ,
Popular ,
Rule 10b-5 ,
Securities Exchange Act ,
Securities Litigation ,
Shareholder Litigation ,
Vaccinations
Delaware Chancery Court Dismisses Cigna Derivative Suit Over Failed Anthem Merger; The PCAOB Sanctions Former KPMG Vice Chair Of Audit For Failure To Supervise Senior Members Of KPMG's Audit Practice; Ninth Circuit Affirms...more
4/21/2022
/ Anthem Insurance ,
Board of Directors ,
Breach of Contract ,
Breach of Duty ,
CEOs ,
CIGNA ,
Civil Monetary Penalty ,
Class Action ,
Coronavirus/COVID-19 ,
Derivative Suit ,
Disgorgement ,
Dismissals ,
False Statements ,
Fiduciary Duty ,
KPMG ,
Material Misstatements ,
Mergers ,
Misleading Statements ,
Omissions ,
PCAOB ,
Publicly-Traded Companies ,
Putative Class Actions ,
Sanctions ,
Sarbanes-Oxley ,
Scienter ,
Securities Exchange Act of 1934 ,
Securities Litigation ,
Securities Transactions ,
Securities Violations ,
Shareholders ,
Short-Swing Trading